However, overexpression of SCD1 is implicated in various metabolic disorders, including obesity, metabolic dysfunction-associated steatotic liver disease (MASLD), insulin resistance, and cancer (11, 12, 13, 14). Here, SCD is linked to metabolic dysfunction-associated steatotic liver disease.